Fig. 2 (abstract P110).
Trametinib augments T-VEC mediated tumor regression in Xenograft melanoma model. NSG mice with SKMEL28 xenograft treated with Trametinib and/or T-VEC
Fig. 2 (abstract P110). | Journal for ImmunoTherapy of Cancer